Jeff Craven

A clinical expert panel from the Sjögren’s Syndrome Foundation has published the first-ever clinical practice guidelines for the disease in the United States.

The study evaluated 2 groups of women from the Nurses’ Health Study (NHS) and NHSII cohorts, examining alcohol consumption and the onset of systemic lupus erythematosus.

Study uses data from the Framingham Offspring Cohort to investigate possible relationships between knee osteoarthritis and components of the metabolic syndrome.

Study uses registry data from Sweden to evaluate heart failure risk before and after diagnosis of rheumatoid arthritis.

EULAR has released new recommendations for rheumatoid arthritis management with disease-modifying antirheumatic drugs.

A phase 3, double-blind, randomized placebo-controlled study was conducted in 551 patients with active rheumatoid arthritis who received secukinumab, abatacept, or placebo.

Phase 3 trial in patients taking baricitinib, adalimumab, or placebo in addition to methotrexate background therapy.

Prospective, observational study assessed 4 treatment protocols and their effects on skin thickening.

Researchers find that higher levels of disease activity predict the development of diabetes mellitus in patients with psoriatic arthritis.

Study followed patients with knee osteoarthritis for 6 months to evaluate improvement in joint pain.

Functional MRI imaging in patients with non-neuropsychiatric systemic lupus erythematosus found that defects in spatial working memory and cognitive dysfunction were related to damage in specific neural networks.

Rituximab significantly reduces mean DAS28 scores in patients with rheumatoid arthritis after retreatment cycles.

The likelihood of regaining ability to work was studied in patients with rheumatoid arthritis who initiated anti-tumor necrosis factor therapy within 5 years.

The prevalence and severity of coronary atherosclerosis, measured by coronary CT angiography, were compared in patients with psoriatic arthritis and age/gender-matched controls.

New research pools data from several clinical trials to examine whether tocilizumab-associated neutropenia was linked to increased risk for serious infection in patients with rheumatoid arthritis.

The risk of hip fracture with diabetes was attenuated after allowing for the competing risk of death.

Data from the Corrona registry found that only 23.0% of patients were considered responders to their first biologic medication at the time of the second follow-up visit.

Secukinumab treatment was associated with higher ASAS 20 response rates at weeks 16, 24, and 52 and ASAS 40 at weeks 24 and 52 compared with treatment with adalimumab.

Nearly half of patients with septic arthritis with poor functional outcome who underwent ultrasonography (US) showed decreased synovial thickness at 3 months compared to baseline.

Patients with clinically suspect arthralgia who have circulating anti-citrullinated protein antibodies (ACPAs) and rheumatoid factor (RF) are at an increased risk of clinical arthritis progression, according to research presented at the American College of Rheumatology 2016 annual meeting. Robin M ten Brinck, PhD candidate from the Department of Rheumatology at Leiden University Medical Center, the…

WASHINGTON, DC — Researchers evaluating the 3-year efficacy of secukinumab found that it safe and efficacious in the treatment of psoriatic arthritis (PsA) across multiple dosages, according to recent research recently presented at the American College of Rheumatology 2016 annual meeting. Philip J Mease, MD, from the Swedish Medical Center and University of Washington, Seattle,…

WASHINGTON, DC — There was no change in safety profile for adalimumab in pediatric patients with polyarticular juvenile idiopathic arthritis (pJIA), enthesitis-related arthritis (ERA), psoriasis (Ps), and Crohn’s disease (CD), a recent analysis showed. The research was presented at the American College of Rheumatology (ACR) 2016 Annual Meeting. Gerd Horneff, MD, from the Asklepios Kliniken GmbH…

A historical analysis suggests that sugar control policies inconsistently cite coronary heart disease as a health risk.

Patients with rheumatoid arthritis have an overestimated risk of fracture when measured with the United Kingdom Fracture Risk Assessment Tool compared with the general population.

A significant association between periodontitis and rheumatoid arthritis is confirmed in a meta-analysis.